The BROADWAY trial shows that obicetrapib significantly lowers LDL cholesterol and Lp(a) in high...
Author - Hippocrates Briefs Team
Association Between Lipoprotein(a) Levels and Recurrent ASCVD...
Elevated lipoprotein(a) levels were linked to higher recurrence risk in a cohort of over 270,000...
Periodontal Bacterium P. gingivalis Linked to Atrial...
Researchers found that the gum bacterium P. gingivalis can migrate to the heart, promoting atrial...
Pulse Rate Complexity Linked to Slower Cognitive Decline in...
Higher pulse rate complexity in older adults was linked to slower cognitive decline, suggesting...
VISUALIZED: Efficacy of Obicetrapib in Reducing LDL Cholesterol...
Read further: Efficacy of Obicetrapib in Reducing LDL Cholesterol and Lp(a) in High-Risk...
Probiotics as a Potential Intervention for Alzheimer’s Disease:...
Probiotic treatment in Alzheimer’s mouse models reduced cognitive decline and inflammation. At the...
Evolocumab Reduces Coronary Plaque Inflammation and Volume in...
Eighteen months of evolocumab therapy significantly reduced high-risk noncalcified plaque and...
Plant-Based Diet Reduces Body Weight and HbA1c in Type 2...
A 12-week online plant-based diet program significantly reduced body weight, HbA1c, and cholesterol...
Regional Differences in Burnout Among U.S. Internal Medicine...
Burnout affects internal medicine physicians across all practice settings. Still, regional...
VISUALIZED: Evolocumab Reduces Coronary Plaque Inflammation and...
Read further: Evolocumab Reduces Coronary Plaque Inflammation and Volume in CAD Patients
